Dualitas Therapeutics Funding: $65M Raised, Series A (2025)
Dualitas Therapeutics is a Biotech company based in South San Francisco. It has raised $65M in total funding. Latest round: Series A.
Dualitas Therapeutics funding overview
Dualitas Therapeutics is a Biotech company based in South San Francisco. Dualitas Therapeutics has raised $65M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in September 2025. The round record for Dualitas Therapeutics runs through 2025; nothing later has been disclosed. Investors on record include Versant Ventures, Qiming Venture Partners USA, SV Health Investors, Chugai Venture Fund, Eli Lilly and Company, Alexandria Venture Investments. 6 distinct backers are named across the disclosed rounds.
Dualitas Therapeutics at a glance
Total raised
$65M
Latest round
Series A
Latest round date
September 2025
Industry
Biotech
Headquarters
South San Francisco
Notable investors
Versant Ventures, Qiming Venture Partners USA, SV Health Investors, Chugai Venture Fund, Eli Lilly and Company, Alexandria Venture Investments
Frequently asked about Dualitas Therapeutics funding
How much has Dualitas Therapeutics raised?
Dualitas Therapeutics has raised $65M in total disclosed funding across the rounds on record.
Who has invested in Dualitas Therapeutics?
Versant Ventures, Qiming Venture Partners USA, SV Health Investors, Chugai Venture Fund, Eli Lilly and Company, Alexandria Venture Investments are named among the investors backing Dualitas Therapeutics.
What was the latest Dualitas Therapeutics funding round?
The most recent disclosed round is a Series A, announced in September 2025.
Where is Dualitas Therapeutics based?
Dualitas Therapeutics is based in South San Francisco.
What sector does Dualitas Therapeutics operate in?
Dualitas Therapeutics is tracked under Biotech from South San Francisco, with $65M in disclosed funding.
When did Dualitas Therapeutics last raise?
The last disclosed Dualitas Therapeutics round closed in September 2025 at Series A.
Totals shown for Dualitas Therapeutics aggregate every disclosed round on file. To see how that compares, browse the Biotech companies in South San Francisco and the investors behind them below.
